Codeine and Tramadol Can Cause Breathing Problems for Children
The FDA is strengthening drug labels for codeine and tramadol to protect children and nursing babies.
More From Around the Web
Check out these Articles
- PDA Pharmaceutical Quality Metrics Conference Offered Industry and U.S. FDA...
- Fighting Diabetes’ Deadly Impact on Minorities
- FDA Approves Keytruda (pembrolizumab) for Advanced Melanoma
- FDA Approves Juvéderm Vollure XC for Correction of Facial Wrinkles and Fol...
- Insurers Are Really Mad at Sovaldi, the $1,000-a-Day Miracle Drug
- FDA Approves Jakafi (ruxolitinib) for Polycythemia Vera
- FDA Approves Striverdi Respimat to Treat Chronic Obstructive Pulmonary Dise...
- FDA Approves Xtoro (finafloxacin) Otic Suspension to Treat Swimmer’s Ear
- FDA Approves Genentech’s Xolair (omalizumab) for Allergic Asthma in Child...
- Here's What's Changing on Nutrition Facts Labels
- Colorectal Cancer: What You Should Know
- FDA's Food and Cosmetic Information Center Answers Your Questions
- FDA Approves Dupixent (dupilumab) for Eczema
- Is It Really 'FDA Approved?'
- HITLAB Completes GCP Audit for FDA Smart Device & App Compliance
- Arsenic levels in rice too low for short-term risk: FDA
- Adult Stem Cell Research Shows Promise
- Indian pharma gets a taste of its own medicine
- FDA Approves Viekira Pak (ombitasvir/paritaprevir/ritonavir with dasabuvir)...
- The Lab for These FDA Scientists Is a Computer Screen
- Allergan Announces FDA Approval of Rhofade (oxymetazoline hydrochloride) Cr...